非侵入性鼻内神经刺激对泪液量、干涩与眼痛的影响
这项回顾性介入病例系列纳入干眼门诊75例受试者,每人接受一次TrueTear鼻内神经刺激;结果泪液量平均增加13.40±8.00 mm,干涩与眼痛评分分别平均下降2.85±2.79和1.48±2.41,但症状改善与泪液量变化不相关。
要点
- 单次鼻内神经刺激可增加泪液量并减轻干涩和眼痛。
- 症状改善与泪液量变化相互独立、不相关。
- 基线泪液量低者泪液量增加更明显。
核心结论
- 鼻内神经刺激增加了泪液量,并降低了干涩与眼痛强度,二者相互独立。
研究设计与样本
- 回顾性介入病例系列,纳入干眼门诊75例受试者,行眼表检查并接受一次神经刺激。
- 结局包括酚红试验测得的泪液量客观变化,以及0-10数值评定量表测得的干涩与眼痛主观变化。
主要发现
- 75例平均年龄59±13岁,男性占73%。
- 鼻内神经刺激使泪液量增加(均值13.40±8.00 mm,p<0.0005)。
- 干涩强度下降(均值-2.85±2.79,p<0.0005),眼痛强度下降(均值-1.48±2.41,p<0.0005)。
- 症状变化与泪液量变化不相关(干涩 r=-0.13,p=0.25;眼痛 r=0.07,p=0.56)。
- 未观察到与神经刺激相关的并发症。
关键数值与推荐
- 多变量模型中泪液量增加的最强预测因素为较低基线泪液量(标准化β=-0.50,p<0.0005)和无自身免疫病(β=-0.36,p=0.001),R2=0.30。
- 干涩与眼痛评分下降的最强预测因素为较低的基线干涩与眼痛评分。
临床怎么用
- 提示单次鼻内神经刺激可作为增加泪液量、缓解干涩与眼痛的干预选项。
- 症状改善与泪液量变化不相关,临床评估需同时关注客观泪液量与主观症状。
局限性
- 回顾性介入病例系列设计,样本来自单一干眼门诊,仅评估一次神经刺激会话。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the effect of one TrueTear session on change in tear volume and symptoms of dryness and ocular pain. METHODS: Retrospective interventional case series of patients seen in a dry eye clinic. Seventy-five individuals underwent an ocular surface examination and one session of neurostimulation. Outcome measures included objective change in tear volume measured via phenol red test, and subjective change in sensations of dryness and ocular pain measured on a 0-10 Numerical Rating Scale. RESULTS: The mean age of the 75 individuals was 59±13 years, and the majority were male (73%). Intranasal neurostimulation increased tear volume (mean 13.40±8.00 mm, p<0.0005) and reduced intensities of dryness (mean -2.85±2.79, p<0.0005) and ocular pain (mean -1.48±2.41, p<0.0005 for both). However, these effects were independent of one another as change in symptom report did not correlate with change in tear volume (r=-0.13, p=0.25 for dryness; r=0.07, p=0.56 for pain). In a multivariable model, the strongest predictors for increased tear volume were lower baseline tear volume (standardised beta (β)=-0.50, p<0.0005) and absence of an autoimmune disease (β=-0.36, p=0.001) (R2=0.30). The strongest predictors for reduced dryness and pain scores were lower baseline dryness and ocular pain scores. No complications related to neurostimulation were noted. CONCLUSION: Intranasal neurostimulation increased tear volume and reduced intensities of dryness and ocular pain, independently of one another.
引用
- Farhangi M, Cheng AM, Baksh B, et al. Effect of non-invasive intranasal neurostimulation on tear volume, dryness and ocular pain. Br J Ophthalmol. 2019. PMID: 31831506. doi:10.1136/bjophthalmol-2019-315065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。